Les carbapénèmes, une possibilité même en ambulatoire ?, p.69 ,
Available from Cours de bactériologie [Internet] Cours de microbiologie de la faculté libre de médecine de Lille Available from: http://anne.decoster.free.fr/bindex.html 3. Philippon A. Cours de bactériologie générale [Internet]. Campus de microbiologie médicale Available from: http://www.microbe-edu.org/index.html 4. Fleming A. Penicillin. Nobel Lecture Available from: http://www.nobelprize.org/nobel_prizes/medicine/laureates Available from Available from, pdf 5. InVS > Résistance aux anti-infectieux > Glossaire [Internet]. Institut de Veille Sanitaire, pp.83-93, 1945. ,
Bacteriology of humans: an ecological perspective, p.351, 2008. ,
Bacterial Community Variation in Human Body Habitats Across Space and Time, Science, vol.326, issue.5960, pp.1694-1701, 2009. ,
DOI : 10.1126/science.1177486
Changing Patterns of Plasmid-Mediated Drug Resistance During Tetracycline Therapy, Antimicrobial Agents and Chemotherapy, vol.11, issue.3, pp.388-91, 1977. ,
DOI : 10.1128/AAC.11.3.388
Excretion of ciprofloxacin in sweat and multiresistant Staphylococcus epidermidis, The Lancet, vol.349, issue.9046, pp.167-176, 1997. ,
DOI : 10.1016/S0140-6736(96)09229-X
Antibiotic Sensitivity Patterns and R Factors in Domestic and Wild Animals, Archives of Environmental Health: An International Journal, vol.7, issue.5, pp.561-568, 1971. ,
DOI : 10.1016/S0140-6736(66)91705-3
Changes in Intestinal Flora of Farm Personnel after Introduction of a Tetracycline-Supplemented Feed on a Farm, New England Journal of Medicine, vol.295, issue.11, pp.583-591, 1976. ,
DOI : 10.1056/NEJM197609092951103
Isolates from Healthy Pig Farmers, Human Controls, and Pigs, Emerging Infectious Diseases, vol.11, issue.5, p.711, 2005. ,
DOI : 10.3201/eid1105.040866
URL : http://doi.org/10.3201/eid1105.040866
A European Study on the Relationship between Antimicrobial Use and Antimicrobial Resistance, Emerging Infectious Diseases, vol.8, issue.3, pp.278-82, 2002. ,
DOI : 10.3201/eid0803.010192
Outpatient antibiotic use in Europe and association with resistance: a cross-national database study, The Lancet, vol.365, issue.9459, pp.579-87, 2005. ,
DOI : 10.1016/S0140-6736(05)70799-6
Address in Pathology on chemotherapeutics : scientific principles, methods, and results, Aug, vol.4694182, issue.164694, pp.445-51, 1913. ,
An Enzyme from Bacteria able to Destroy Penicillin, Nature, vol.146, issue.3713, pp.837-837, 1940. ,
DOI : 10.1038/146837a0
Une histoire de la résistance aux antibiotiques : A propos de six bactéries. Paris: L'Harmattan, 2009. ,
Report of the joint committee on the use of antibiotics in animal husbandry and veterinary medicine. London: Her Majesty's Stationary Office, 1969. ,
Observatoire national de l'épidémiologie de la résistance aux antibiotiques (Onerba) en France : 15 ans d'histoire. Bull Épidémiologique Santé Anim Aliment, 2012. ,
Surveillance des bactéries multirésistantes dans les établissements de santé en France. Résultats 2002. Saint-Maurice: Institut de veille sanitaire, p.31, 2002. ,
Le bon usage des antibiotiques, 2002. ,
Plan antibiotiques [Internet]. Plan antibiotiques -Moins prescrire d'antibiotiques, c'est préserver leur efficacité. Available from ,
Système Européen de Surveillance de la Résistance Antimicrobienne (EARSS): objectifs et organisation, Euro Surveill, vol.4, issue.4, pp.41-45, 1999. ,
Journée mondiale de la santé 2011: Organisation mondiale de la Santé Available from: http://www.who.int/world-health- day, Avril, 2011. ,
Maîtrise de la diffusion des bactéries multirésistantes aux antibiotiques -Ministère des Affaires sociales et de la Santé -www ,
Surveillance des bactéries multirésistantes dans les établissements de santé en France Réseau BMR-Raisin ? Résultats, 2011. ,
Hong Kong strains of methicillin-resistant and methicillin-sensitive Staphylococcus aureus have similar virulence, Journal of Hospital Infection, vol.15, issue.2, pp.117-142, 1990. ,
DOI : 10.1016/0195-6701(90)90120-D
Virulence Factors of Escherichia coli Isolates That Produce CTX-M-Type Extended-Spectrum ??-Lactamases, Antimicrobial Agents and Chemotherapy, vol.49, issue.11, pp.4667-70, 2005. ,
DOI : 10.1128/AAC.49.11.4667-4670.2005
Pathogenic Significance of Methicillin Resistance for Patients with Staphylococcus aureus Bacteremia, Clinical Infectious Diseases, vol.30, issue.2, pp.368-73, 2000. ,
DOI : 10.1086/313650
10 x '20 Progress--Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America, Clinical Infectious Diseases, vol.56, issue.12, pp.1685-94, 2013. ,
DOI : 10.1093/cid/cit152
Infections liées aux soins réalisés en dehors des établissements de santé -guide de prévention. Ministère de la Santé et des Solidarités, 0128. ,
Society's failure to protect a precious resource: antibiotics, The Lancet, vol.378, issue.9788, pp.369-71, 2011. ,
DOI : 10.1016/S0140-6736(11)60401-7
Sauvons les antibiotiques, Alliance Contre le développement des Bactéries Multi-Résistantes aux Antibiotiques, 2011. ,
DOI : 10.1016/j.medmal.2011.06.003
New anti-infectives company, Allecra Therapeutics, created with ?15 million series a financing ,
Probiotics: A new way to fight bacterial pulmonary infections? Médecine Mal Infect, 2013. ,
The rationale for probiotics in female urogenital healthcare, MedGenMed Medscape Gen Med, vol.6, issue.1, p.49, 2004. ,
; a preliminary report of efficacy, Clinical Otolaryngology, vol.8, issue.4, pp.349-57, 2009. ,
DOI : 10.1111/j.1749-4486.2009.01973.x
Bacteriophages MR299-2 and NH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells. mBio, pp.29-41, 2012. ,
Cranberries for preventing urinary tract infections Available from, Cochrane Database of Systematic Reviews [Internet], 2008. ,
Cranberries for preventing urinary tract infections In: The Cochrane Collaboration Available from, Cochrane Database of Systematic Reviews [Internet], 2012. ,
Extended-Spectrum ??-Lactamases: a Clinical Update, Clinical Microbiology Reviews, vol.18, issue.4, pp.657-86, 2005. ,
DOI : 10.1128/CMR.18.4.657-686.2005
Defining an extended-spectrum ??-lactamase, Clinical Microbiology and Infection, vol.14, issue.s1, pp.3-10, 2008. ,
DOI : 10.1111/j.1469-0691.2007.01857.x
URL : http://doi.org/10.1111/j.1469-0691.2007.01857.x
Available from: http://fr.wikipedia.org/wiki/Fichier:Conjugation.svg, 2009. ,
A functional classification scheme for beta-lactamases and its correlation with molecular structure, Antimicrobial Agents and Chemotherapy, vol.39, issue.6, pp.1211-1244, 1995. ,
DOI : 10.1128/AAC.39.6.1211
The ABCD???s of ??-lactamase nomenclature, Journal of Infection and Chemotherapy, vol.19, issue.4, pp.549-59, 2013. ,
DOI : 10.1007/s10156-013-0640-7
Ubertragbare Resistenz gegen??ber Cefotaxim, Cefoxitin, Cefamandol und Cefuroxim in klinischen Isolaten von Klebsiella pneumoniae und Serratia marcescens, Infection, vol.147, issue.6, pp.315-322, 1983. ,
DOI : 10.1007/BF01641355
: identification of CTX-1, a novel ??-lactamase, Journal of Antimicrobial Chemotherapy, vol.20, issue.3, pp.323-357, 1987. ,
DOI : 10.1093/jac/20.3.323
Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. The Lancet, pp.302-308, 1987. ,
Dissemination of the novel plasmid-mediated beta-lactamase CTX-1, which confers resistance to broad-spectrum cephalosporins, and its inhibition by beta-lactamase inhibitors., Antimicrobial Agents and Chemotherapy, vol.32, issue.1, pp.9-14, 1988. ,
DOI : 10.1128/AAC.32.1.9
Extended-spectrum beta-lactamases., Antimicrobial Agents and Chemotherapy, vol.33, issue.8, p.1131, 1989. ,
DOI : 10.1128/AAC.33.8.1131
Les nouvelles bêta-lactamases à spectre étendu (BLSE) Mises au Point en Anesthésie- Réanimation [Internet]. MAPAR éditions Available from: http://www.mapar.org/article, pp.203-212, 2008. ,
Growing Group of Extended-Spectrum ??-Lactamases: the CTX-M Enzymes, Antimicrobial Agents and Chemotherapy, vol.48, issue.1, pp.1-14 ,
DOI : 10.1128/AAC.48.1.1-14.2004
CTX-M: changing the face of ESBLs in Europe, Journal of Antimicrobial Chemotherapy, vol.59, issue.2, pp.165-74, 2007. ,
DOI : 10.1093/jac/dkl483
Extended-spectrum ??-lactamase-producing Enterobacteriaceae: an emerging public-health concern, The Lancet Infectious Diseases, vol.8, issue.3, pp.159-66, 2008. ,
DOI : 10.1016/S1473-3099(08)70041-0
The CTX-M ??-lactamase pandemic, Current Opinion in Microbiology, vol.9, issue.5, pp.466-75, 2006. ,
DOI : 10.1016/j.mib.2006.08.011
Les bêta-lactamases à spectre étendu : le défi s'accentue, Ann Biol Clin (Paris), vol.70, issue.2, pp.117-157, 2012. ,
Bactéries multirésistantes (BMR) en milieu hospitalier : entérobactéries productrices de ?-lactamases à spectre étendu (EBLSE) et Staphylococcus aureus résistants à la méticilline (SARM), pp.42-43473, 2002. ,
Surveillance des Bactéries Multi Résistantes. Résultats -Année 2011. CCLIN-Ouest, p.89 ,
Extended spectrum beta-lactamase production and fluorquinolone resistance in pathogens associated with community acquired urinary tract infection, Diagnostic Microbiology and Infectious Disease, vol.32, issue.4, pp.317-326, 1998. ,
DOI : 10.1016/S0732-8893(98)00113-8
Antibiotic Susceptibility of Bacterial Strains Isolated from Patients with Community-Acquired Urinary Tract Infections in France, European Journal of Clinical Microbiology & Infectious Diseases, vol.19, issue.2, pp.112-119, 2000. ,
DOI : 10.1007/s100960050440
Population-Based Laboratory Surveillance for Escherichia coli-Producing Extended-Spectrum ??-Lactamases: Importance of Community Isolates with blaCTX-M Genes, Clinical Infectious Diseases, vol.38, issue.12, pp.1736-1777, 2004. ,
DOI : 10.1086/421094
Epidemiology and Clinical Features of Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Nonhospitalized Patients, Journal of Clinical Microbiology, vol.42, issue.3, pp.1089-94, 2004. ,
DOI : 10.1128/JCM.42.3.1089-1094.2004
Extended spectrum beta-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: trends in the hospital and community settings, J Infect Dev Ctries, vol.3, issue.04, pp.295-304, 2009. ,
Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum ??-lactamases in the UK, Journal of Antimicrobial Chemotherapy, vol.54, issue.4, pp.735-778, 2004. ,
DOI : 10.1093/jac/dkh424
Influx of Extended-Spectrum ??-Lactamase--Producing Enterobacteriaceae into the Hospital, Clinical Infectious Diseases, vol.42, issue.7, pp.925-959, 2006. ,
DOI : 10.1086/500936
Extended-spectrum ??-lactamase (ESBL)-producing enterobacteria: factors associated with infection in the community setting, Auckland, New Zealand, Journal of Hospital Infection, vol.68, issue.4, pp.355-62, 2008. ,
DOI : 10.1016/j.jhin.2008.02.003
Identification and Broad Dissemination of the CTX-M-14 ??-Lactamase in Different Escherichia coli Strains in the Northwest Area of Spain, Journal of Clinical Microbiology, vol.40, issue.11, pp.4030-4036, 2002. ,
DOI : 10.1128/JCM.40.11.4030-4036.2002
Bacteremia Due to Extended-Spectrum ??-Lactamase-Producing Escherichia coli in the CTX-M Era: A New Clinical Challenge, Clinical Infectious Diseases, vol.43, issue.11, pp.1407-1421, 2006. ,
DOI : 10.1086/508877
Prevalence of fecal carriage of extended-spectrum ??-lactamase-producing Enterobacteriaceae among healthy adult people in Japan, Journal of Infection and Chemotherapy, vol.17, issue.5, pp.722-727, 2011. ,
DOI : 10.1007/s10156-011-0225-2
Fecal carriage of extended-spectrum ?lactamase-producing Enterobacteriaceae in Korean community and hospital settings, Infection, 2012. ,
Faecal carriage of ESBL-producing Enterobacteriaceae and carbapenem-resistant Gram-negative bacilli in community settings, The Journal of Infection in Developing Countries, vol.7, issue.08, pp.630-634, 2013. ,
DOI : 10.3855/jidc.2900
High community faecal carriage rates of CTX-M ESBL-producing Escherichia coli in a specific population group in Birmingham, UK, Journal of Antimicrobial Chemotherapy, vol.67, issue.5, pp.1108-1121, 2012. ,
DOI : 10.1093/jac/dks018
High prevalence of ESBL-producing Enterobacteriaceae carriage in Dutch community patients with gastrointestinal complaints, Clinical Microbiology and Infection, vol.19, issue.6, pp.542-551 ,
DOI : 10.1111/j.1469-0691.2012.03947.x
Prevalence and characterisation of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli isolates in healthy volunteers in Tunisia, European Journal of Clinical Microbiology & Infectious Diseases, vol.46, issue.7, pp.1511-1517, 2011. ,
DOI : 10.1007/s10096-011-1471-z
Community faecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceaein french children, BMC Infectious Diseases, vol.41, issue.5, p.315, 2012. ,
DOI : 10.1093/jac/dkl326
10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum ??-lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre, Journal of Antimicrobial Chemotherapy, vol.68, issue.3, pp.562-570, 2009. ,
DOI : 10.1093/jac/dks429
URL : https://hal.archives-ouvertes.fr/hal-00802788
High rate of extended-spectrum beta-lactamases (ESBL)-producing enterobacteria and contribution of quantitative digestive carriage in patients hospitalised in an infectious diseases unit, 2013. ,
Duration of Stool Colonization in Healthy Medical Students with Extended-Spectrum-??-Lactamase-Producing Escherichia coli, Antimicrobial Agents and Chemotherapy, vol.56, issue.8, pp.4558-4567, 2012. ,
DOI : 10.1128/AAC.00171-12
Duration of Stool Colonization in Patients Infected with Extended?Spectrum ??Lactamase?Producing Escherichia coli and Klebsiella pneumoniae, Clin Infect Dis Apr, vol.1546, issue.8, pp.1322-1325, 2008. ,
Duration of colonization by extended-spectrum ??-lactamase-producing Enterobacteriaceae after hospital discharge, American Journal of Infection Control, vol.41, issue.5, pp.443-450, 2013. ,
DOI : 10.1016/j.ajic.2012.05.015
Duration of colonization with extended-spectrum betalactamase-producing Escherichia coli in patients with travellers' diarrhoea, Scand J Infect Dis, 2012. ,
Long-term carriage of extended-spectrum beta-lactamase-producing Escherichia coli, Scandinavian Journal of Infectious Diseases, vol.77, issue.1, pp.51-55 ,
DOI : 10.3109/00365548.2011.592987
High Rate of Intestinal Colonization with Extended-Spectrum-??-Lactamase-Producing Organisms in Household Contacts of Infected Community Patients, Journal of Clinical Microbiology, vol.46, issue.8, pp.2796-2805, 2008. ,
DOI : 10.1128/JCM.01008-08
Intrafamilial transmission of extended-spectrum-??-lactamase-producing Escherichia coli and Salmonella enterica Babelsberg among the families of internationally adopted children, Journal of Antimicrobial Chemotherapy, vol.65, issue.5, pp.859-65, 2010. ,
DOI : 10.1093/jac/dkq068
Fecal carriage of CTXM type extended-spectrum beta-lactamase-producing organisms by children and their household contacts, Journal of Infection, vol.60, issue.4, pp.286-92, 2010. ,
DOI : 10.1016/j.jinf.2010.02.002
Community-onset extended-spectrum ??-lactamase (ESBL) producing Escherichia coli: Importance of international travel, Journal of Infection, vol.57, issue.6, pp.441-449, 2008. ,
DOI : 10.1016/j.jinf.2008.09.034
Extended-spectrum beta-lactamaseproducing Escherichia coli in patients with travellers' diarrhoea, Scand J Infect Dis, 2010. ,
Foreign Travel Is a Major Risk Factor for Colonization with Escherichia coli Producing CTX-M-Type Extended-Spectrum ??-Lactamases: a Prospective Study with Swedish Volunteers, Antimicrobial Agents and Chemotherapy, vol.54, issue.9, pp.3564-3572, 2010. ,
DOI : 10.1128/AAC.00220-10
Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-??-lactamase-producing Escherichia coli among companion animals, Journal of Antimicrobial Chemotherapy, vol.65, issue.4, pp.651-60, 2010. ,
DOI : 10.1093/jac/dkq004
Extended-spectrum ??-lactamase-producing Enterobacteriaceae in healthy companion animals living in nursing homes and in the community, American Journal of Infection Control, vol.41, issue.9, pp.831-836, 2013. ,
DOI : 10.1016/j.ajic.2012.11.013
Extended-Spectrum ??-Lactamases in Escherichia coli Isolated from Dogs and Cats in Rome, Italy, from 2001 to 2003, Antimicrobial Agents and Chemotherapy, vol.49, issue.2, pp.833-838, 2001. ,
DOI : 10.1128/AAC.49.2.833-835.2005
Sharing of Escherichia coli Sequence Type ST131 and Other Multidrug-Resistant and Urovirulent E. coli Strains among Dogs and Cats within a Household, Journal of Clinical Microbiology, vol.47, issue.11, pp.3721-3726, 2009. ,
DOI : 10.1128/JCM.01581-09
Animal reservoirs for extended spectrum ??-lactamase producers, Clinical Microbiology and Infection, vol.14, pp.117-140, 2008. ,
DOI : 10.1111/j.1469-0691.2007.01851.x
Imported chicken meat as a potential source of quinolone-resistant Escherichia coli producing extended-spectrum ??-lactamases in the UK, Journal of Antimicrobial Chemotherapy, vol.61, issue.3, pp.504-512, 2008. ,
DOI : 10.1093/jac/dkm517
IncN plasmids carrying blaCTX-M-1 in Escherichia coli isolates on a dairy farm, Veterinary Microbiology, vol.149, issue.3-4, pp.3-4513, 2011. ,
DOI : 10.1016/j.vetmic.2010.11.032
ESBL-and plasmidic class C ?-lactamaseproducing E. coli strains isolated from poultry, pig and rabbit farms, Vet Microbiol, vol.118, pp.3-4299, 2006. ,
DOI : 10.1016/j.vetmic.2006.08.002
Community Infections Caused by Extended-Spectrum ??-Lactamase???Producing Escherichia coli, Archives of Internal Medicine, vol.168, issue.17, p.1897, 2008. ,
DOI : 10.1001/archinte.168.17.1897
Risk Factors and Prognosis, Clinical Infectious Diseases, vol.50, issue.1, pp.40-48, 2010. ,
DOI : 10.1086/649537
Clinical Implications, Risk Factors and Mortality Following Community-onset Bacteremia Caused by Extended-spectrum ??-lactamase (ESBL) and non-ESBL Producing Escherichia coli, Journal of Microbiology, Immunology and Infection, vol.43, issue.3, pp.240-248, 2010. ,
DOI : 10.1016/S1684-1182(10)60038-2
URL : http://doi.org/10.1016/s1684-1182(10)60038-2
Clinical characteristics of urosepsis caused by extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumonia and their emergence in the community, Journal of Microbiology, Immunology and Infection, vol.45, issue.2, pp.127-160, 2012. ,
DOI : 10.1016/j.jmii.2011.09.029
Nationwide survey of extended-spectrum ??-lactamase-producing Enterobacteriaceae in the French community setting, Journal of Antimicrobial Chemotherapy, vol.63, issue.6, pp.1205-1219, 2009. ,
DOI : 10.1093/jac/dkp108
URL : https://hal.archives-ouvertes.fr/hal-00426312
MedQual : surveillance de l'évolution des résistances des souches d'escherichia coli isolées en ville. Bull Épidémiologique Santé Anim Aliment, pp.21-25, 2012. ,
Risk Factors for the Development of Extended-Spectrum Beta-Lactamase-Producing Bacteria in Nonhospitalized Patients, European Journal of Clinical Microbiology & Infectious Diseases, vol.23, issue.3, pp.163-170, 2004. ,
DOI : 10.1007/s10096-003-1084-2
A Multinational Survey of Risk Factors for Infection with Extended???Spectrum ?????Lactamase???Producing Enterobacteriaceae in Nonhospitalized Patients, Clinical Infectious Diseases, vol.49, issue.5, pp.682-90, 2009. ,
DOI : 10.1086/604713
URL : https://hal.archives-ouvertes.fr/hal-00426315
Risk factors for extended-spectrum ?-lactamase positivity in uropathogenic Escherichia coli isolated from communityacquired urinary tract infections, Clin Microbiol Infect. Feb, vol.16, issue.2, pp.147-51, 2010. ,
Epidemiology and Risk Factors of Community Onset Infections Caused by Extended-Spectrum ??-Lactamase-Producing Escherichia coli Strains, Journal of Clinical Microbiology, vol.50, issue.2, pp.312-319, 2011. ,
DOI : 10.1128/JCM.06002-11
Risk factors for community- and health facility???acquired extended-spectrum ??-lactamase???producing bacterial infections in patients at the University of Minnesota Medical Center, Fairview, American Journal of Infection Control, vol.40, issue.9, pp.849-53, 2012. ,
DOI : 10.1016/j.ajic.2011.10.019
Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum ??-lactamases, Journal of Antimicrobial Chemotherapy, vol.57, issue.4, pp.780-783, 2006. ,
DOI : 10.1093/jac/dkl035
Impact of Extended-spectrum ??-lactamase-producing Escherichia coli and Klebsiella pneumoniae on the Outcome of Community-onset Bacteremic Urinary Tract Infections, Journal of Microbiology, Immunology and Infection, vol.43, issue.3, pp.194-203, 2010. ,
DOI : 10.1016/S1684-1182(10)60031-X
Clinical characteristics of communityacquired acute pyelonephritis caused by ESBL-producing pathogens in South Korea, Infection, 2013. ,
Nitrofurantoïne et risque de survenue d'effets indésirables hépatiques et pulmonaires lors de traitements prolongés [Internet] Available from: http://ansm.sante.fr/S- informer/Informations-de-securite-Lettres-aux-professionnels-de-sante/Nitrofurantoine-et-risque-desurvenue-d-effets-indesirables-hepatiques-et-pulmonaires-lors-de-traitements-prolonges-Lettre-auxprofessionnels-de-sante, 2011. ,
Restriction d'utilisation de la nitrofurantoïne en raison d'un risque de survenue d'effets indésirables graves hépatiques et pulmonaires ,
Infections urinaires communautaires : vers une révision des recommandations. Clermont-Ferrand, 2013. ,
Nitrofurantoin in the treatment of extended-spectrum ??-lactamase-producing Escherichia coli-related lower urinary tract infection, International Journal of Antimicrobial Agents, vol.40, issue.6, pp.554-560, 2012. ,
DOI : 10.1016/j.ijantimicag.2012.08.003
Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infections, International Journal of Antimicrobial Agents, vol.29, issue.1, pp.62-67, 2007. ,
DOI : 10.1016/j.ijantimicag.2006.08.039
Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum ??-lactamase producing, Enterobacteriaceae infections: a systematic review, The Lancet Infectious Diseases, vol.10, issue.1, pp.43-50, 2010. ,
DOI : 10.1016/S1473-3099(09)70325-1
Fosfomycin susceptibility among extended-spectrum-??-lactamase-producing Escherichia coli in Nottingham, UK, Journal of Antimicrobial Chemotherapy, vol.65, issue.5, pp.1076-1083, 2010. ,
DOI : 10.1093/jac/dkq051
Oral Treatment Options for Ambulatory Patients with Urinary Tract Infections Caused by Extended-Spectrum-??-Lactamase-Producing Escherichia coli, Antimicrobial Agents and Chemotherapy, vol.54, issue.9, pp.4006-4014, 2010. ,
DOI : 10.1128/AAC.01760-09
Parallel increase in community use of fosfomycin and resistance to fosfomycin in extended-spectrum ??-lactamase (ESBL)-producing Escherichia coli, Journal of Antimicrobial Chemotherapy, vol.65, issue.11, pp.2459-63, 2010. ,
DOI : 10.1093/jac/dkq346
Pivmecillinam versus sulfamethizole for short-term treatment of uncomplicated acute cystitis in general practice: A randomized controlled trial. Scand J Prim Health Care, pp.6-11, 2009. ,
Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: The LUTIW project, Scandinavian Journal of Primary Health Care, vol.52, issue.2, pp.49-57, 2007. ,
DOI : 10.2165/00003495-199100424-00005
Alternatives to carbapenems in ESBL-producing Escherichia coli infections. Médecine Mal Infect, Feb, vol.43, issue.2, pp.62-68, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00802661
Observatoire de la Médecine Générale [Internet] Available from ,
Caisse Nationale d'Assurance Maladie, p.33, 2008. ,
Infections urinaires communautaires: les recommandations de l'AFSSAPS de 2008 sont-elles toujours adaptées à l'écologie bactérienne actuelle? [Thèse d'exercice, 2011. ,
Etude des résistances bactériennes dans les infections urinaires communautaires: quelles conséquences pour les antibiothérapies probabilistes en médecine de ville? [Thèse d'exercice, 2011. ,
Analyse de la prescription antibiotique des médecins généralistes en Haute- Vienne dans le traitement des infections urinaires de l'adulte [Thèse d'exercice]. Limoges, 2011. ,
Analyse de la prise en charge de l'infection urinaire en médecine générale. A propos de 88 cas observés en médecine praticienne [Thèse d'exercice, 2003. ,
Diagnostic et traitement des infections urinaires basses de la femme: enquête auprès des médecins généralistes d'Indre-et-Loire, Ecole doctorale Santé, sciences, technologies, 1986. ,
Evaluation du traitement antibiotique des cystites aiguës simples chez les médecins généralistes d'Ille-et-Vilaine [Thèse d'exercice, 2011. ,
Infection urinaire de l'enfant: prise en charge initiale enquête auprès des médecins généralistes du Doubs [Thèse d'exercice, 2006. ,
infection urinaire chez l'enfant: évolution des pratiques en médecine générale, Thèse d'exercice, 2004. ,
Le médecin généraliste de ville face aux infections urinaires basses chez la femme adulte: à propos de trois cents cas [Thèse d'exercice, 1985. ,
Prise en charge des infections urinaires en médecine générale: état des connaissances et étude de pratique par entretiens confraternels auprès de 57 médecins généralistes de Haute-Normandie [Thèse d'exercice, 2008. ,
Prise en charge des infections urinaires fébriles de l'adulte en médecine générale: une enquête de pratique [Thèse d'exercice], 2009. ,
Deuxième conférence de consensus en thérapeutique anti-infectieuse: antibiothérapie des infections urinaires -16 Novembre, Médecine Mal Infect. Feb, vol.21, issue.2, pp.51-55, 1990. ,
SELEXID 200 mg, comprimé pelliculé [Internet] Haute Autorité de Santé Available from, 2013. ,
Examens préinterventionnels systématiques. Annales francaises d'anesthesie et de reanimation, 2012. ,
Issy-les-Moulineaux: Vidal, 2013. ,
Available from: http://www.merck.ca, Merck Canada Inc, 1975. ,
Le kit BLSE, un outil d'aide à la prise en charge des infections urinaires communautaires à E. coli porteur de Béta- Lactamase à Spectre Elargi (BLSE) [Internet]. Clermont-Ferrand; 2013 Available from ,
Etude des pratiques des médecins généralistes dans la prise en charge des infections urinaires à entérobactéries sécrétrices de bêta-lactamase à spectre étendu [Thèse d'exercice], 2013. ,
DOI : 10.1016/s0399-077x(14)70249-5